Indian vaccine giant Serum plans African plant in global expansion
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Wednesday
June 29, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
WEDNESDAY, JUNE 29, 2022
Indian vaccine giant Serum plans African plant in global expansion

Global Economy

Reuters
24 May, 2022, 10:30 am
Last modified: 24 May, 2022, 10:39 am

Related News

  • India's Serum Institute applies for full approval of Covishield vaccine
  • Serum Institute pledges $66 million to Oxford University for research
  • Serum sends 4.5M AstraZeneca doses to Bangladesh
  • Omicron-specific booster shot possible: SII CEO Adar Poonawalla
  • Serum Institute to resume supply of Covishield to Covax: Reports

Indian vaccine giant Serum plans African plant in global expansion

Reuters
24 May, 2022, 10:30 am
Last modified: 24 May, 2022, 10:39 am
Photo :UNB
Photo :UNB

The Serum Institute of India (SII), the world's biggest vaccine maker, is considering setting up its first manufacturing plant in Africa as it looks to expand globally after its success in selling Covid-19 shots, its CEO told Reuters on Monday.

Africa was the only continent that did not have its own manufacturing capacity for Covid shots during the worst phases of the pandemic in the last two years, leaving it at the mercy of suppliers from overseas, including the SII.

"It's never been a better time to be a vaccine manufacturer. I'm looking at expanding our manufacturing across the globe," SII Chief Executive Adar Poonawalla said during an interview at the World Economic Forum in Davos.

"There are some great countries out there: South Africa, Rwanda, you know, to name a few that we're looking at."

Poonawalla said he was meeting some African officials in Davos to discuss his plans. Asked about possible investments, he said such projects typically required at least around $300 million.

He did not say what products an African plant might make. Apart from Covid shots, the SII's Indian plants make vaccines for diphtheria, BCG, measles, rubella and other conditions.

Asked about concerns over the rise of monkeypox cases, Poonawalla said he believed the disease was not so infectious.

"We'll wait and see even if we want to make a vaccine for it," he said.

Monkeypox is usually mild and is endemic in parts of west and central Africa. The World Health Organization has said it expects to identify more cases as it expands surveillance in countries where the disease is not typically found.

On Covid, the SII has sold more than 1.5 billion doses in India of the AstraZeneca shot it makes and brands Covishield, and exported millions more.

But as demand has now waned, the company is putting its Indian Covishield facilities on standby and will "not produce anything there", Poonawalla said, while adding it could resume output if needed.

The SII has also pulled the plug on a plan to produce and sell about 300 million doses of Russia's Sputnik Light Covid vaccine. However, it is still making millions of doses of a version of the Novavax Covid shot for India and other countries, Poonawalla said.

He estimated privately held SII was now valued at roughly $20 billion, but said there was no immediate plan to go public.

Top News / World+Biz / South Asia

Serum Institute / Serum Institute of India / Serum Institute of India (SII)

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Bangladesh expects $5.5b from WB, IMF in budget support
    Bangladesh expects $5.5b from WB, IMF in budget support
  • Advance tax hits construction sector hard: Entrepreneurs
    Advance tax hits construction sector hard: Entrepreneurs
  • Representational Image: Collected
    ABB concerned over mandatory tax return submission for SME loans

MOST VIEWED

  • Russian 1000-rouble banknotes, 50 and 10 kopeck coins are seen on a table at a private company's office in Krasnoyarsk, Siberia November 6, 2014. Photo: Reuters
    Rouble firms past 52 against dollar for first time since May 2015
  • A man holds a wheat in a grain storage facility near Izmail, in the Odessa region on June 14, amid the Russian invasion of Ukraine. Photographer: Oleksandr Gimanov/AFP/Getty Images
    Food inflation relief is within sight as crops and crude pull back
  • An Iranian flag flutters in front of the International Atomic Energy Agency (IAEA) headquarters in Vienna, Austria, 15 January 2016. REUTERS/Leonhard Foeger
    Iran applies to join China and Russia in BRICS club
  • Bank Indonesia headquarters in Jakarta.Photographer: Rony Zakaria/Bloomberg
    Central banks in Asia spend billions to slow currency declines
  • Industrial facilities of PCK Raffinerie oil refinery are pictured in Schwedt/Oder, Germany, May 9, 2022. The company receives crude oil from Russia via the 'Friendship' pipeline. REUTERS/Hannibal Hanschke/File Photo
    Why Russian oil price cap is easier said than done
  • FILE PHOTO: The logo of Toshiba Corp. is seen at the company's facility in Kawasaki, Japan June 10, 2021. REUTERS/Kim Kyung-Hoon/File Photo
    Toshiba board gains two directors from activist funds in historic shift

Related News

  • India's Serum Institute applies for full approval of Covishield vaccine
  • Serum Institute pledges $66 million to Oxford University for research
  • Serum sends 4.5M AstraZeneca doses to Bangladesh
  • Omicron-specific booster shot possible: SII CEO Adar Poonawalla
  • Serum Institute to resume supply of Covishield to Covax: Reports

Features

Abortion is a part of healthcare. Photo: Bloomberg

Abortion is healthcare and women’s rights are human rights

11h | Panorama
Prashanta Kumar Banerjee. Sketch: TBS

'Public Asset Management Company can be an additional tool to curb bad loans'

12h | Interviews
Aid boats navigate through the different waters of Jamalganj Upazila, giving aid to flood victims.  Photo: Masum Billah

Bandits, hunger and snakes: Flood victims pass sleepless nights

14h | Panorama
Redmi 10C- Best Budget smartphone with one (big) compromise

Redmi 10C- Best Budget smartphone with one (big) compromise

1d | Brands

More Videos from TBS

Why teachers are being humiliated again and again?

Why teachers are being humiliated again and again?

2h | Videos
After Bangabandhu Bridge, will Padma Bridge change economy again?

After Bangabandhu Bridge, will Padma Bridge change economy again?

3h | Videos
 Fuel for non-essential vehicles banned in Sri Lanka

Fuel for non-essential vehicles banned in Sri Lanka

5h | Videos
Christiano Ronaldo to join Chelsea?

Christiano Ronaldo to join Chelsea?

5h | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Desco wanted to make a bold statement with their new head office building, a physical entity that would be a corporate icon. Photo: Courtesy
Habitat

Desco head office: When commitment to community and environment inspires architecture

3
Japan cancels financing Matarbari coal project phase 2
Bangladesh

Japan cancels financing Matarbari coal project phase 2

4
Photo: Courtesy
Corporates

Gree AC being used in all parts of Padma Bridge project

5
Photo: TBS
Infrastructure

Gains from Padma Bridge to cross $10b, hope experts

6
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
Workers unload boats and stockpile sacks of paddy at the BOC Ghat paddy market on the bank of the River Meghna in Brahmanbaria’s Ashuganj, the largest paddy market in the eastern part of the country. This century-old market sells paddies worth Tk5-6 crore a day during the peak season. PHOTO: RAJIB DHAR

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net